|
| [26] | G. Cullaro, R. Sharma, J. Trebicka, A. Cárdenas, E. C. Verna,
"Precipitants of Acute-on-Chronic Liver Failure: An Opportunity for Preventative Measures to Improve Outcomes", Liver transplantation, vol. 26, no. 2, 2019, pp. 283–293.
|
| [25] | A. Queck, D. Thomas, C. Jansen, Y. Schreiber, S. Rüschenbaum, M. Praktiknjo, K. M. Schwarzkopf, M. M. Mücke, R. Schierwagen, F. E. Uschner, C. Meyer, J. Clària, S. Zeuzem, G. Geisslinger, J. Trebicka, C. M. Lange,
"Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis", PLOS ONE, vol. 14, no. 10, 2019, pp. e0222840.
|
|
| [24] | F. Benz, A. Bogen, M. Praktiknjo, C. Jansen, C. Meyer, A. Wree, M. Demir, S. Loosen, M. Vucur, R. Schierwagen, F. Tacke, J. Trebicka, C. Roderburg,
"Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis", PLOS ONE, vol. 15, no. 4, 2020, pp. e0231701.
|
| [23] | C. Cremonese, R. Schierwagen, F. E. Uschner, S. Torres, O. Tyc, C. Ortiz, M. Schulz, A. Queck, G. Kristiansen, M. Bader, T. Sauerbruch, R. Weiskirchen, T. Walther, J. Trebicka, S. Klein,
"Short-Term Western Diet Aggravates Non-Alcoholic Fatty Liver Disease (NAFLD) With Portal Hypertension in TGR(mREN2)27 Rats", International journal of molecular sciences, vol. 21, no. 9, 2020, pp. 3308.
|
| [22] | L. M. Klein, J. Chang, W. Gu, S. Manekeller, C. Jansen, P. Lingohr, M. Praktiknjo, J. C. Kalf, M. Schulz, U. Spengler, C. Strassburg, A. Cárdenas, V. Arroyo, J. Trebicka,
"The Development and Outcome of Acute-on-Chronic Liver Failure After Surgical Interventions", Liver transplantation, vol. 26, no. 2, 2020, pp. 227–237.
|
| [21] | A. Queck, H. Bode, F. E. Uschner, M. J. Brol, C. Graf, M. Schulz, C. Jansen, M. Praktiknjo, R. Schierwagen, S. Klein, C. Trautwein, H. E. Wasmuth, M. Berres, J. Trebicka, J. Lehmann,
"Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis", Frontiers in immunology, vol. 11, 2020, pp. 354.
|
| [20] | R. Schierwagen, F. E. Uschner, C. Ortiz, S. Torres, M. J. Brol, O. Tyc, W. Gu, C. Grimm, S. Zeuzem, A. Plamper, P. Pfeifer, S. Zimmer, C. Welsch, L. Schaefer, K. P. Rheinwalt, J. Clària, V. Arroyo, J. Trebicka, S. Klein,
"The Role of Macrophage-Inducible C-Type Lectin in Different Stages of Chronic Liver Disease", Frontiers in immunology, vol. 11, 2020, pp. 1352.
|
| [19] | R. Schierwagen, P. Dietrich, S. Klein, F. E. Uschner, C. Ortiz, O. Tyc, S. Torres, C. Hellerbrand, T. Sauerbruch, J. Trebicka,
"β-Arrestin2 is increased in liver fibrosis in humans and rodents", Proceedings of the National Academy of Sciences of the United States of America, vol. 117, no. 44, 2020, pp. 27082–27084.
|
| [18] | K. M. Schwarzkopf, L. Eberle, F. E. Uschner, S. Klein, R. Schierwagen, M. M. Mücke, L. Schaefer, J. Clària, S. Zeuzem, E. Hintermann, U. Christen, C. M. Lange, J. Trebicka, C. Welsch,
"Interleukin-22 in acute-on-chronic liver failure: A matter of ineffective levels, receptor dysregulation or defective signalling?", Journal of hepatology, vol. 73, no. 4, 2020, pp. 980–982.
|
| [17] | M. Thiele, M. B. Hugger, Y. Kim, P. Rautou, L. Elkrief, C. Jansen, W. Verlinden, G. Allegretti, M. Israelsen, H. Stefanescu, F. Piscaglia, J. C. García-Pagán, S. Franque, A. Berzigotti, L. Castera, W. K. Jeong, J. Trebicka, A. Krag,
"2D shear wave liver elastography by aixplorer to detect portal hypertension in cirrhosis: an individual patient data meta-analysis", Liver international, vol. 40, no. 6, 2020, pp. 1435–1446.
|
| [16] | S. Torres, Z. Abdullah, M. J. Brol, C. Hellerbrand, M. Fernandez, R. Fiorotto, S. Klein, P. Königshofer, C. Liedtke, S. Lotersztajn, Y. A. Nevzorova, R. Schierwagen, T. Reiberger, F. E. Uschner, F. Tacke, R. Weiskirchen, J. Trebicka,
"Recent Advances in Practical Methods for Liver Cell Biology", International journal of molecular sciences, vol. 21, no. 6, 2020, pp. 2027.
|
| [15] | J. Zeng-Brouwers, S. Pandey, J. Trebicka, M. Wygrecka, L. Schaefer,
"Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune Diseases", Journal of histochemistry & cytochemistry, vol. 68, no. 12, 2020, pp. 887–906.
|
|
| [14] | H. Innes, H. D. Nischalke, I. N. Guha, K. H. Weiss, W. Irving, D. Gotthardt, E. Barnes, J. Fischer, M. A. Ansari, J. Rosendahl, S. Lin, A. Marot, V. Pedergnana, M. Casper, J. Benselin, F. Lammert, J. McLauchlan, P. L. Lutz, V. Hamill, S. Mueller, J. R. Morling, G. Semmler, F. Eyer, J. von Felden, A. Link, A. Vogel, J. U. Marquardt, S. Sulk, J. Trebicka, L. Valenti, C. Datz, T. Reiberger, C. Schafmayer, T. Berg, P. Deltenre, J. Hampe, F. Stickel, S. Buch,
"The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis", Hepatology communications, 2021.
|
| [13] | Y. Iwakiri, J. Trebicka,
"Portal hypertension in cirrhosis", JHEP reports, vol. 3, no. 4, 2021, pp. 100316.
|
| [12] | S. Monteiro, J. Grandt, F. E. Uschner, N. Kimer, J. L. Madsen, R. Schierwagen, S. Klein, C. Welsch, L. Schäfer, C. Jansen, J. Claria, J. Alcaraz-Quiles, V. Arroyo, R. Moreau, J. Fernandez, F. Bendtsen, G. Mehta, L. L. Gluud, S. Møller, M. Praktiknjo, J. Trebicka,
"Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation", Gut, vol. 70, 2021, pp. 379–387.
|
| [11] | A. Queck, F. E. Uschner, P. G. Ferstl, M. Schulz, M. J. Brol, M. Praktiknjo, R. Schierwagen, S. Klein, C. P. Strassburg, C. Meyer, C. Jansen, M. Berres, J. Trebicka,
"Role of circulating angiogenin levels in portal hypertension and TIPS", PLOS ONE, vol. 16, no. 8, 2021, pp. e0256473.
|
| [10] | S. Torres, M. J. Brol, F. Magdaleno, R. Schierwagen, F. E. Uschner, S. Klein, C. Ortiz, O. Tyc, N. Bachtler, J. Stunden, D. Bertheloot, A. Kitanovic, B. Sanchez, J. Schrum, W. R. Roush, L. Franchi, K. Byth, E. Latz, J. Trebicka,
"The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis", Frontiers in molecular biosciences, vol. 8, 2021, pp. 715765.
|
| [9] | J. Trebicka, J. Macnaughtan, B. Schnabl, D. L. Shawcross, J. S. Bajaj,
"The microbiota in cirrhosis and its role in hepatic decompensation", Journal of hepatology, vol. 75, no. Supplement 1, 2021, pp. S67–S81.
|
| [8] | J. Trebicka, P. Bork, A. Krag, M. Arumugam,
"Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure", Nature reviews / Gastroenterology & hepatology, vol. 18, no. 3, 2021, pp. 167–180.
|
| [7] | T. Wirtz, P. A. Reuken, C. Jansen, P. Fischer, I. Bergmann, C. Backhaus, C. Emontzpohl, J. Reißing, E. F. Brandt, M. T. Koenen, K. M. Schneider, R. Schierwagen, M. J. Brol, J. Chang, H. W. Zimmermann, N. Köse-Vogel, T. Eggermann, I. Kurth, C. Stoppe, R. Bucala, J. Bernhagen, M. Praktiknjo, A. Stallmach, C. Trautwein, J. Trebicka, T. Bruns, M. Berres,
"Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis", JHEP reports, vol. 3, no. 2, 2021, pp. 100221.
|
|
| [6] | A. R. P. Schneider, C. V. Schneider, K. M. Schneider, V. Baier, S. Schaper, C. Diedrich, K. Coboeken, H. Mayer, W. Gu, J. Trebicka, L. M. Blank, R. Burghaus, J. Lippert, D. J. Rader, C. A. Thaiss, J. Schlender, C. Trautwein, L. Küpfer,
"Early prediction of decompensation (EPOD) score: Non-invasive determination of cirrhosis decompensation risk", Liver international, vol. 42, no. 3, 2022, pp. 640–650.
|
|
| [5] | A. Queck, L. Schwierz, W. Gu, P. G. Ferstl, C. Jansen, F. E. Uschner, M. Praktiknjo, J. Chang, M. J. Brol, F. Schepis, M. Merli, C. P. Strassburg, J. Lehmann, C. Meyer, J. Trebicka,
"Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS", Hepatology, vol. 77, no. 2, 2023, pp. 466–475.
|
| [4] | J. Soppert, E. F. Brandt, N. M. Heussen, E. Barzakova, L. M. Blank, L. Küpfer, M. W. Hornef, J. Trebicka, J. Jankowski, M. Berres, H. Noels,
"Blood endotoxin levels as biomarker of non-alcoholic fatty liver disease: a systematic review and meta-analysis", Clinical Gastroenterology and Hepatology, vol. 21, no. 11, 2023, pp. 2746–2758.
|
| [3] | S. Torres, C. Ortiz, N. Bachtler, W. Gu, L. D. Grünewald, N. Kraus, R. Schierwagen, C. Hieber, C. Meier, O. Tyc, M. Joseph Brol, F. E. Uschner, B. Nijmeijer, C. Welsch, M. Berres, C. Garcia-Ruiz, J. C. Fernandez-Checa, C. Trautwein, T. J. Vogl, S. Zeuzem, J. Trebicka, S. Klein,
"Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis", Hepatology, vol. 77, no. 4, 2023, pp. 1228–1240.
|
| [2] | J. Trebicka, A. Zarbock,
"Editorial: terlipressin in patients with acute-on-chronic liver failure grade 3—too late?", Alimentary pharmacology & therapeutics, vol. 57, no. 1, 2023, pp. 177–178.
|
|
| [1] | S. Bartimoccia, M. Praktiknjo, C. Nocella, R. Schierwagen, V. Cammisotto, C. Jansen, L. Cristiano, V. Castellani, J. Chang, R. Carnevale, S. Maiucci, F. E. Uschner, P. Pignatelli, M. J. Brol, J. Trebicka, F. Violi,
"Association between endotoxemia and blood no in the portal circulation of cirrhotic patients: results of a pilot study", Internal and emergency medicine, 2024.
|